Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
暂无分享，去创建一个
B. Devellis | B. Gandek | R. Devellis | R. Landewé | D. Furst | E. Losina | B. Natvig | A. Weinstein | S. Burbine | D. Lacaille | C. Barnabe | A. Paltiel | Alexa Smith | K. Hagen | M. Greenwald | K. Luijtens | A. Harmer | W. Koetse | N. Østerås | P. Bertin | Stephanie P Chen | Kristina M. Klara | S. Florentinus | R. Noormohamed | O. Davies | L. Nairn | S. Shaikh | B. Bennett | F. Staelens | Nanette Alvarez | Annie S. Y. Han | Peter Faris | Edward H Yelin | Ross Crawford | Daniel H. Solomon | Lisa G. Suter | David J. Hunter | Jack Crosbie | Rochelle P Walensky | Betsy L. Sleath | Susan J. Blalock | Deborah A Marshall | C. E. Barber | E. Keystone | Marlene Fransen | Betty Chewning | Beth L Jonas | J. Esdaile | Liam O. Martin | Glen S Hazlewood | G. B. J. Mancini | Stephanie Keeling | J. Antonio Aviñ A-Zubieta | Mikkel Østergaard | Shufang Liu | Désirée van der Heijde | Karin Magnusson | Lars Nordsletten | I. K. Haugen | Lyn March | David Parker | Jeffrey N Katz